Vitamin D’s Impact on Cancer Incidence and Mortality: A Systematic Review
Nutrients · 16.07.2025 · 17 (14) · 2333
DOI: 10.3390/nu17142333 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Nutrients, online erschienen am 16.07.2025. Verfasst von Sunil J Wimalawansa. Beteiligte Einrichtung: CardioMetabolic & Endocrine Institute, North Brunswick, NJ, USA. Hauptthemen laut MEDLINE: Neoplasms, Vitamin D, Vitamin D Deficiency. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 416 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Adequate vitamin D levels are essential for various physiological functions, including cell growth, immune modulation, metabolic regulation, DNA repair, and overall health span. Despite its proven cost-effectiveness, widespread deficiency persists due to inadequate supplementation and limited sunlight exposure.
Methods
This systematic review (SR) examines the relationship between vitamin D and the reduction of cancer risk and mortality, and the mechanisms involved in cancer prevention. This SR followed the PRISMA and PICOS guidelines and synthesized evidence from relevant studies.
Results
Beyond genomic actions via calcitriol [1,25(OH)2D]-receptor interactions, vitamin D exerts cancer-protective effects through mitigating inflammation, autocrine, paracrine, and membrane signaling. The findings reveal a strong inverse relationship between serum 25(OH)D levels and the incidence, metastasis, and mortality of several cancer types, including colon, gastric, rectal, breast, endometrial, bladder, esophageal, gallbladder, ovarian, pancreatic, renal, vulvar cancers, and both Hodgkin’s and non-Hodgkin’s lymphomas. While 25(OH)D levels of around 20 ng/mL suffice for musculoskeletal health, maintaining levels above 40 ng/mL (100 nmol/L: range, 40–80 ng/mL) significantly lowers cancer risks and mortality.
Conclusions
While many observational studies support vitamin D’s protective role in incidents and deaths from cancer, some recent mega-RCTs have failed to demonstrate this. The latter is primarily due to critical study design flaws, like recruiting vitamin D sufficient subjects, inadequate dosing, short durations, and biased designs in nutrient supplementation studies. Consequently, conclusions from these cannot be relied upon. Well-designed, adequately powered clinical trials using appropriate methodologies, sufficient vitamin D3 doses, and extended durations consistently demonstrate that proper supplementation significantly reduces cancer risk and markedly lowers cancer mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CardioMetabolic & Endocrine Institute, North Brunswick, NJ, USA.
ORCID-Profile: Sunil J Wimalawansa
Zitieren
APA
Wimalawansa, S. J. (2025). Vitamin D’s Impact on Cancer Incidence and Mortality: A Systematic Review. Nutrients, 17(14), 2333. https://doi.org/10.3390/nu17142333
Vancouver
Wimalawansa SJ. Vitamin D’s Impact on Cancer Incidence and Mortality: A Systematic Review. Nutrients. 2025;17(14):2333. doi:10.3390/nu17142333
BibTeX
@article{Wimalawansa2025,
author = {Wimalawansa, Sunil J},
title = {Vitamin D’s Impact on Cancer Incidence and Mortality: A Systematic Review},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {14},
pages = {2333},
doi = {10.3390/nu17142333}
}
EUVIMED